NCT02650453 Ongoing Registry of Deep Venous Reconstructions
| NCT ID | NCT02650453 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maastricht University Medical Center |
| Condition | Venous Thrombosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2009-09 |
| Primary Completion | 2019-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2009-09 with a primary completion date of 2019-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ongoing registration of deep venous obstructive disease patients treated by means of percutaneous transluminal angioplasty (PTA) and stenting with or without endophlebectomy (surgical desobstruction, also termed endovenectomy) of the common femoral vein and/or arteriovenous fistula creation.
Eligibility Criteria
Inclusion Criteria: * Venous obstruction/occlusion in the femoral vein, common femoral vein, external iliac vein, common iliac vein or inferior vena cava Exclusion Criteria: * Intolerance to anticoagulant medication * A life expectancy \<1 year
Contact & Investigator
Mark A de Wolf, MD
✉ m.dewolf@maastrichtuniversity.nlCees Wittens, MD, PhD
PRINCIPAL INVESTIGATOR
Maastricht University Medical Centre
Frequently Asked Questions
Who can join the NCT02650453 clinical trial?
This trial is open to participants of all sexes, studying Venous Thrombosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02650453 currently recruiting?
Yes, NCT02650453 is actively recruiting participants. Contact the research team at m.dewolf@maastrichtuniversity.nl for enrollment information.
Where is the NCT02650453 trial being conducted?
This trial is being conducted at Maastricht, Netherlands.
Who is sponsoring the NCT02650453 clinical trial?
NCT02650453 is sponsored by Maastricht University Medical Center. The principal investigator is Cees Wittens, MD, PhD at Maastricht University Medical Centre. The trial plans to enroll 1,000 participants.